Total Payments
$169,574
2024 Payments
$62,455
Companies
8
Transactions
287
Medicare Patients
151
Medicare Billing
$12,914
Payment Breakdown by Category
Other$137,600 (81.1%)
Travel$24,212 (14.3%)
Food & Beverage$7,074 (4.2%)
Education$688.14 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130,400 | 61 | 76.9% |
| Travel and Lodging | $24,212 | 98 | 14.3% |
| Food and Beverage | $7,074 | 116 | 4.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,700 | 2 | 2.8% |
| Honoraria | $2,500 | 1 | 1.5% |
| Education | $688.14 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $122,059 | 189 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $41,937 | 75 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $4,991 | 5 | $0 (2017) |
| AbbVie Inc. | $450.79 | 11 | $0 (2021) |
| MILLICENT US INC | $71.29 | 4 | $0 (2024) |
| PFIZER INC. | $27.06 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $19.83 | 1 | $0 (2018) |
| Pacira Pharmaceuticals Incorporated | $18.37 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,455 | 105 | Astellas Pharma US Inc ($62,375) |
| 2023 | $59,702 | 89 | Astellas Pharma US Inc ($59,684) |
| 2021 | $86.70 | 4 | AbbVie Inc. ($86.70) |
| 2020 | $20.47 | 1 | AbbVie Inc. ($20.47) |
| 2019 | $4,699 | 13 | AMAG Pharmaceuticals, Inc. ($4,523) |
| 2018 | $33,771 | 63 | AMAG Pharmaceuticals, Inc. ($33,665) |
| 2017 | $8,840 | 12 | Valeant Pharmaceuticals North America LLC ($4,991) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Biological | ||||||
| 12/04/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Biological | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $493.16 | General |
| Category: Biological | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $161.28 | General |
| Category: Biological | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $71.98 | General |
| Category: Biological | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Biological | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Biological | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $321.60 | General |
| Category: Biological | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $156.78 | General |
| Category: Biological | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Biological | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Biological | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $155.44 | General |
| Category: Biological | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Biological | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Biological | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Biological | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $13.27 | General |
| Category: Biological | ||||||
| 10/24/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/22/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: WOMENS HEALTH | ||||||
| 10/08/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 09/18/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Biological | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 68 | 81 | $18,694 | $6,186 |
| 2021 | 4 | 55 | 62 | $10,896 | $4,974 |
| 2020 | 2 | 28 | 32 | $4,456 | $1,754 |
Total Patients
151
Total Services
175
Medicare Billing
$12,914
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,866 | $2,372 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 29 | $4,379 | $1,531 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 18 | $3,996 | $1,452 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,453 | $831.12 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,002 | $1,679 | 42.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 15 | $2,720 | $1,389 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 20 | $2,300 | $1,387 | 60.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 14 | 14 | $1,874 | $518.70 | 27.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 18 | $1,908 | $952.60 | 49.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,548 | $801.30 | 31.4% |
About Dr. Corey Babb, D.O
Dr. Corey Babb, D.O is a Gynecology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427218593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corey Babb, D.O has received a total of $169,574 in payments from pharmaceutical and medical device companies, with $62,455 received in 2024. These payments were reported across 287 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($130,400).
As a Medicare-enrolled provider, Babb has provided services to 151 Medicare beneficiaries, totaling 175 services with total Medicare billing of $12,914. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Tulsa, OK
- Active Since 06/12/2008
- Last Updated 10/05/2022
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1427218593
Products in Payments
- Veozah (Drug) $121,459
- INTRAROSA (Drug) $38,638
- ADDYI (Drug) $4,991
- BREMELANOTIDE (Drug) $3,299
- Orilissa (Drug) $176.37
- Lupron (Drug) $99.99
- FEMRING (Drug) $71.29
- ORILISSA (Drug) $70.11
- LO LOESTRIN FE (Drug) $37.06
- PREMARIN (Drug) $27.06
- Essure (Device) $19.83
- EXPAREL (Drug) $18.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Tulsa
Karen Gold, Md, MD
Gynecology — Payments: $1,488
Gynecology $1,488
Dr. Jay Weinstein, M.d, M.D
Gynecology
Gynecology
Max Deardorff, M.d, M.D
Gynecology
Gynecology
Dr. Richard Polk, D.o, D.O
Gynecology
Gynecology
Dr. Kathleen Carlson, Md, MD
Gynecology
Gynecology
Kathryn Bynum, Aprn, APRN
Gynecology
Gynecology